On 23 April, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. Read more of our submission.

Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of...

www.england.nhs.uk/2015/01/11/beat-cancer On Sunday 11th January 2015 NHS England announced details of a new independent taskforce being...

As a member of the Cancer Drug Fund (CDF) Charity Group Cancer52 has signed an open letter to Professor Peter Clark, Chair of the CDF....

We are delighted to be hosting a parliamentary event in December 2014, hosted by John Baron MP, Chair of the All-Party Parliamentary...

On 31st October 2014 Cancer52 submitted its response to the NHS England Consultation: Proposals for a sustainable Cancer Drugs Fund. You...

The National Cancer Patient Experience Survey 2014 was published this morning. Our comment on its publication is here.

Cancer52, an alliance of 80 charities working in the field of rare and less common cancers is today (19th September 2014) publishing its...

The Joint VBA Statement, prepared alongside Genetic Alliance UK, which nearly half our members signed, was submitted on Friday 12th...

Cancer52 welcomes the new additional investment of £160 million in the Cancer Drugs Fund (CDF) announced by Health Secretary Jeremy Hunt...